Volume 13, Issue 1 (Feb 2025)
Res Mol Med (RMM) 2025, 13(1): 1-8 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Karimbakhsh M, Eramian M, Gholami M. Staphylococcus haemolyticus: Tackling Multidrug Resistance and Biofilm Hurdles–Advances in Antimicrobial Strategies: A Review Study. Res Mol Med (RMM) 2025; 13 (1) :1-8
URL: http://rmm.mazums.ac.ir/article-1-598-en.html
URL: http://rmm.mazums.ac.ir/article-1-598-en.html
1- Department of Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
2- Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Molecular and Cell Biology Research Centre, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. ,mehrdad_gholami90@yahoo.com
2- Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Molecular and Cell Biology Research Centre, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. ,
Keywords: Staphylococcus haemolyticus, Multidrug resistance (MDR), Biofilm, Antimicrobial peptides, Phage therapy
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
